Your browser doesn't support javascript.
loading
Eculizumab versus rituximab in generalised myasthenia gravis.
Nelke, Christopher; Schroeter, Christina B; Stascheit, Frauke; Pawlitzki, Marc; Regner-Nelke, Liesa; Huntemann, Niklas; Arat, Ercan; Öztürk, Menekse; Melzer, Nico; Mergenthaler, Philipp; Gassa, Asmae; Stetefeld, Henning; Schroeter, Michael; Berger, Benjamin; Totzeck, Andreas; Hagenacker, Tim; Schreiber, Stefanie; Vielhaber, Stefan; Hartung, Hans-Peter; Meisel, Andreas; Wiendl, Heinz; Meuth, Sven G; Ruck, Tobias.
Afiliação
  • Nelke C; Department of Neurology, Heinrich Heine University Düsseldorf, Dusseldorf, Germany.
  • Schroeter CB; Department of Neurology, Heinrich Heine University Düsseldorf, Dusseldorf, Germany.
  • Stascheit F; Department of Neurology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Pawlitzki M; NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Regner-Nelke L; Department of Neurology, Heinrich Heine University Düsseldorf, Dusseldorf, Germany.
  • Huntemann N; Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster, Germany.
  • Arat E; Department of Neurology, Heinrich Heine University Düsseldorf, Dusseldorf, Germany.
  • Öztürk M; Department of Neurology, Heinrich Heine University Düsseldorf, Dusseldorf, Germany.
  • Melzer N; Department of Neurology, Heinrich Heine University Düsseldorf, Dusseldorf, Germany.
  • Mergenthaler P; Department of Neurology, Heinrich Heine University Düsseldorf, Dusseldorf, Germany.
  • Gassa A; Department of Neurology, Heinrich Heine University Düsseldorf, Dusseldorf, Germany.
  • Stetefeld H; Department of Neurology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Schroeter M; NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Berger B; Department of Cardiothoracic Surgery, University Hospital Cologne, Koln, Germany.
  • Totzeck A; Departement of Neurology, Uniklinik Koln, Koln, Nordrhein-Westfalen, Germany.
  • Hagenacker T; Department of Neurology, University of Cologne, Koln, Germany.
  • Schreiber S; Department of Neurology and Neurophysiology, University Hospital Freiburg, Freiburg, Germany.
  • Vielhaber S; Department of Neurology, University Hospital Essen, Essen, Germany.
  • Hartung HP; Department of Neurology, University Hospital Essen, Essen, Germany.
  • Meisel A; Department of Neurology, Otto-von-Guericke University, Magdeburg, Germany.
  • Wiendl H; Otto von Guericke Universität Magdeburg, Magdeburg, Sachsen-Anhalt, Germany.
  • Meuth SG; Department of Neurology, Heinrich Heine University Düsseldorf, Dusseldorf, Germany.
  • Ruck T; Department of Neurology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
J Neurol Neurosurg Psychiatry ; 93(5): 548-554, 2022 05.
Article em En | MEDLINE | ID: mdl-35246490
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anticorpos Monoclonais Humanizados / Miastenia Gravis Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anticorpos Monoclonais Humanizados / Miastenia Gravis Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha